BIOMAT Database Logo BIOMAT Database Logo

[Subcutaneous heparin therapy]. 1967

R Raynaud, and M Brochier, and B Chatelain

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R Raynaud, and M Brochier, and B Chatelain
[Subcutaneous heparin therapy].
November 1993, Soins; la revue de reference infirmiere,
R Raynaud, and M Brochier, and B Chatelain
Plasma heparin concentrations during subcutaneous heparin therapy.
October 1976, Australian and New Zealand journal of medicine,
R Raynaud, and M Brochier, and B Chatelain
Hypertransaminasemia with subcutaneous heparin therapy.
December 1981, Israel journal of medical sciences,
R Raynaud, and M Brochier, and B Chatelain
[Subcutaneous heparin therapy in surgery].
January 1967, Marseille medical,
R Raynaud, and M Brochier, and B Chatelain
Low-dose subcutaneous heparin therapy.
January 1990, New York state journal of medicine,
R Raynaud, and M Brochier, and B Chatelain
Full dose subcutaneous heparin therapy.
July 1989, New York state journal of medicine,
R Raynaud, and M Brochier, and B Chatelain
Measurement of heparin in patients receiving subcutaneous heparin therapy.
June 1975, British journal of haematology,
R Raynaud, and M Brochier, and B Chatelain
[Subcutaneous heparin therapy in cardiologic practice].
January 1969, Annales de cardiologie et d'angeiologie,
R Raynaud, and M Brochier, and B Chatelain
EFFECTIVE SUBCUTANEOUS HEPARIN THERAPY IN MYOCARDIAL INFARCTION.
July 1963, The American journal of the medical sciences,
R Raynaud, and M Brochier, and B Chatelain
Life-threatening hemorrhage following subcutaneous heparin therapy.
February 2009, Therapeutics and clinical risk management,
Copied contents to your clipboard!